Asthma is a common lung disease affecting approximately 300 million people worldwide. It is a chronic inflammatory disorder of the airways Symptoms of asthma including wheezing, shortness of breath, chest tightness, cough. It leads to bronchospasm and reversible airflow obstruction. Asthma is often classified as atopic (extrinsic) or non-atopic (intrinsic). Treatment therefore typically involves allergen exposure reduction. Medical treatments include agents to reduce bronchospasm like beta-2-agonists and anti-cholinergics, or immunosuppressive agents like corticosteroids.
Stem cell research to control airway reactive disease has been ongoing. Exploring the the anti-inflammatory and immuno-modulatory properties of adult stem cells to ameliorate asthma. The effects of SVF (rich in mesenchymal stem cells and growth factors) on chronic asthma are being investigated at OC Regenerative Medicine. The protocol includes a combination of intravenous and nebulized SVF delivery. The protocol is performed under local anesthesia is all done as an outpatient. The entire cellular surgical procedure takes approximately 3 hours.